MCP
Mirador Capital Partners’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77M | Buy |
144,347
+45,222
| +46% | +$1.49M | 0.77% | 33 |
|
|
2025
Q1 | $3.98M | Buy |
99,125
+33,489
| +51% | +$1.35M | 0.7% | 37 |
|
|
2024
Q4 | $3.09M | Buy |
65,636
+1,010
| +2% | +$47.5K | 0.56% | 41 |
|
|
2024
Q3 | $3.41M | Buy |
64,626
+1,483
| +2% | +$78.3K | 0.61% | 42 |
|
|
2024
Q2 | $3.42M | Buy |
63,143
+27,688
| +78% | +$1.5M | 0.64% | 40 |
|
|
2024
Q1 | $2.49M | Sell |
35,455
-13,497
| -28% | -$946K | 0.47% | 49 |
|
|
2023
Q4 | $4.09M | Sell |
48,952
-6,676
| -12% | -$557K | 0.87% | 30 |
|
|
2023
Q3 | $1.64M | Buy |
55,628
+1,890
| +4% | +$55.7K | 0.37% | 60 |
|
|
2023
Q2 | $1.75M | Sell |
53,738
-2,846
| -5% | -$92.8K | 0.42% | 61 |
|
|
2023
Q1 | $1.99M | Sell |
56,584
-2,148
| -4% | -$75.6K | 0.47% | 52 |
|
|
2022
Q4 | $2.69M | Sell |
58,732
-69,753
| -54% | -$3.2M | 0.64% | 39 |
|
|
2022
Q3 | $6.23M | Sell |
128,485
-35,098
| -21% | -$1.7M | 1.5% | 17 |
|
|
2022
Q2 | $6.43M | Buy |
163,583
+4,085
| +3% | +$160K | 1.52% | 18 |
|
|
2022
Q1 | $5.87M | Buy |
159,498
+6,879
| +5% | +$253K | 1.19% | 21 |
|
|
2021
Q4 | $6.96M | Sell |
152,619
-10,857
| -7% | -$495K | 1.46% | 19 |
|
|
2021
Q3 | $5.84M | Buy |
163,476
+4,977
| +3% | +$178K | 1.33% | 21 |
|
|
2021
Q2 | $3.14M | Buy |
158,499
+9,415
| +6% | +$186K | 0.71% | 46 |
|
|
2021
Q1 | $3.47M | Sell |
149,084
-3,311
| -2% | -$77K | 0.89% | 37 |
|
|
2020
Q4 | $3.17M | Buy |
152,395
+40,271
| +36% | +$837K | 0.87% | 41 |
|
|
2020
Q3 | $2.43M | Buy |
112,124
+16,017
| +17% | +$347K | 0.76% | 44 |
|
|
2020
Q2 | $2.27M | Sell |
96,107
-1,247
| -1% | -$29.4K | 0.85% | 39 |
|
|
2020
Q1 | $1.62M | Sell |
97,354
-5,122
| -5% | -$85.2K | 0.68% | 46 |
|
|
2019
Q4 | $1.09M | Buy |
+102,476
| New | +$1.09M | 0.44% | 64 |
|